HT
OTC · HTDS
Hard to Treat Diseases Inc.
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 3:30 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 109.65K
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- $0.00 – $0.00
- Volume
- 10K
- Avg. volume
- 227.19K
Price performance
HTDS price history
1M range · 8 trading sessions · Daily adjusted prices
HTDS closed at $0.00 after 8 trading sessions.
- Last close
- $0.00
- Period change
- —
- Period low
- $0.00
- Period high
- $0.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 10K |
| Sep 4, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 1M |
| Aug 28, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 100K |
| Aug 26, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 741.56K |
| Aug 24, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 175K |
| Aug 19, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 45K |
| Aug 18, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 500K |
| Aug 17, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 5.21M |
Latest HTDS news
The latest Smart Investors Daily articles mentioning HTDS.
Stock researchCompany · Overview
HTDS research
Overview
Company profile and research snapshot.
Company profile
HARD TO TREAT DISEASES
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
